BioSpace News Archive

First drug consisting of a rationally-defined bacterial consortium to advance to Phase 2 study

Forbion today announces that its portfolio company Staten Biotechnology B.V. and Novo Nordisk A/S have entered into a collaboration and exclusive option agreement to develop novel therapeutics for the treatment of hypertriglyceridaemia.

PharmaEssentia today announced that the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Besremi, intended for the treatment of polycythaemia vera without symptomatic splenomegaly. The applicant for Besremi is AOP Orphan Pharmaceuticals AG (AOP Orphan).

Device will be paired with Aortica Corp.’s AortaFit™ Automated Fenestration Alignment Software to Simplify Treatment of Complex AAA Disease / Provide Personalized Vascular Therapy

Virion Biotherapeutics today announced the appointment of Edwin Moses, PhD, former CEO of Ablynx, as Chairman of its Board of Directors.

Company Reaffirms 2018 Annual Guidance

I-Mab Biopharma and CSPC Pharmaceutical Group Co., Ltd. jointly announced a strategic partnership between the two companies.

Mallinckrodt Pharmaceuticals will present on Monday, Jan. 7, 2019, at the 37th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis on Union Square, 335 Powell St., San Francisco.

Avanos Medical, Inc. today announced that David Ball has been appointed senior vice president, global supply chain & procurement

St. Jude Children’s Research Hospital® partner iHeartMedia mobilized 35 radio stations across the country and collectively raised more than $7 million during its annual Country Cares for St. Jude Kids national radiothon Dec. 6-7, shattering last year’s record.